Tag:
Timothy C. Rodell
Latest Headlines
Latest Headlines
GlobeImmune lands $41M venture round
With its lead drug in Phase II for pancreatic cancer and a hepatitis C drug slated to forge into a mid-stage study later this year, GlobeImmune has rounded up $41.2 million in its third round of
